These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6586630)

  • 21. Hepatic peroxisomal changes induced by a tetrazole-substituted alkoxyacetophenone in rats and comparison with other species.
    Eacho PI; Foxworthy PS; Johnson WD; Hoover DM; White SL
    Toxicol Appl Pharmacol; 1986 May; 83(3):430-7. PubMed ID: 3754661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of fatty acid beta-oxidation and peroxisome proliferation in the liver of rhesus monkeys by DL-040, a new hypolipidemic agent.
    Lalwani ND; Reddy MK; Ghosh S; Barnard SD; Molello JA; Reddy JK
    Biochem Pharmacol; 1985 Oct; 34(19):3473-82. PubMed ID: 3840374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unusual responses of rat hepatic and renal peroxisomes to RMI 14, 514, a new hypolipidemic agent.
    Svoboda DJ
    J Cell Biol; 1978 Sep; 78(3):810-22. PubMed ID: 29903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of gemfibrozil on serum lipids in man.
    Fenderson RW; Deutsch S; Menachemi E; Chin B; Samuel P
    Angiology; 1982 Sep; 33(9):581-93. PubMed ID: 6751166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carcinogen bioassay and mutagenicity studies with the hypolipidemic agent gemfibrozil.
    Fitzgerald JE; Sanyer JL; Schardein JL; Lake RS; McGuire EJ; de la Iglesia FA
    J Natl Cancer Inst; 1981 Nov; 67(5):1105-16. PubMed ID: 7029098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ciprofibrate--racemate and enantiomers: effects of a four-week treatment on male inbred Fischer rats. A biochemical and morphological study.
    Klinger W; Lupp A; Karge E; Oelschläger H; Rothley D; Danz M; Linss W; Löbel S; Deufel T; Müller M; Klinger M; Kühnel W
    Exp Toxicol Pathol; 1998 Sep; 50(4-6):301-14. PubMed ID: 9784002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrastructural observation of changes in (hepatic) peroxisomes by 3 to 90 days administration of bezafibrate in male rats.
    Kondo K; Makita T
    J Vet Med Sci; 1996 Aug; 58(8):743-8. PubMed ID: 8877972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphometric analysis of the ultrastructural changes in rat liver induced by the peroxisome proliferator SaH 42-348.
    Moody DE; Reddy JK
    J Cell Biol; 1976 Dec; 71(3):768-80. PubMed ID: 993270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of action of gemfibrozil on lipoprotein metabolism.
    Saku K; Gartside PS; Hynd BA; Kashyap ML
    J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effect of phenobarbital on peroxisome biogenesis in mouse hepatocytes.
    Kanamura S; Kanai K; Asaka Y; Watanabe J
    J Ultrastruct Mol Struct Res; 1988 Sep; 100(3):269-77. PubMed ID: 3243975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time-dependent effects of the hypolipidemic agent clofibrate on peroxisomes and mitochondria in mouse hepatocytes.
    Meijer J; Starkerud C; Granell I; Afzelius BA
    J Submicrosc Cytol Pathol; 1991 Apr; 23(2):185-94. PubMed ID: 2070346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gemfibrozil decreases platelet reactivity in patients with hypercholesterolemia during physical stress.
    Laustiola K; Lassila R; Koskinen P; Pellinen T; Manninen V
    Clin Pharmacol Ther; 1988 Mar; 43(3):302-7. PubMed ID: 3278823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of hepatic peroxisome proliferation in nonrodent species, including primates.
    Reddy JK; Lalwani ND; Qureshi SA; Reddy MK; Moehle CM
    Am J Pathol; 1984 Jan; 114(1):171-83. PubMed ID: 6691413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig, and marmoset.
    Lake BG; Evans JG; Gray TJ; Körösi SA; North CJ
    Toxicol Appl Pharmacol; 1989 Jun; 99(1):148-60. PubMed ID: 2499080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperlipoproteinemia, atherosclerosis and gemfibrozil.
    Nash DT
    Angiology; 1982 Sep; 33(9):594-602. PubMed ID: 6957155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proliferation of myocardial peroxisomes caused by several agents and conditions.
    Zipper J
    J Mol Cell Cardiol; 1997 Jan; 29(1):149-61. PubMed ID: 9040030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of clofibrate and gemfibrozil on the activities of mitochondrial carnitine acyltransferases in rat liver. Dose--response relations.
    Kähönen MT; Ylikahri RH
    Atherosclerosis; 1979 Jan; 32(1):47-56. PubMed ID: 465113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisome proliferation and microsomal enzyme induction by the hypolipidemic CI-924 in rats and mice: relationship to tumorgenicity.
    Hofstra AH; King LM; Walker RM
    Fundam Appl Toxicol; 1995 Sep; 27(2):277-86. PubMed ID: 8529824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alkylthio acetic acids (3-thia fatty acids)--a new group of non-beta-oxidizable peroxisome-inducing fatty acid analogues--II. Dose-response studies on hepatic peroxisomal- and mitochondrial changes and long-chain fatty acid metabolizing enzymes in rats.
    Berge RK; Aarsland A; Kryvi H; Bremer J; Aarsaether N
    Biochem Pharmacol; 1989 Nov; 38(22):3969-79. PubMed ID: 2574577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphometry of abnormal peroxisomes induced by withdrawal of bezafibrate, a hypolipidemic drug in male rat hepatocytes.
    Kondo K; Makita T
    J Vet Med Sci; 1997 Apr; 59(4):297-9. PubMed ID: 9152941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.